India's pharma stocks fall as Trump outlines steep tariffs on generic drug imports
BUZZ-India's pharma stocks fall as Trump outlines steep tariffs on generic drug imports ** India's pharma stocks fall in morning trading
** U.S. President Donald Trump says imported generic drugs will remain tariff-free for two years from August 1, before tariffs increase to 100% for one year and 200% thereafter
** Nifty Pharma Index .NIPHARM down 1.01% amid a 0.7% decline in Nifty 50 Index .NSEI
** Shares of Aurobindo Pharma ARBN.NS down 2.9%, Sun Pharmaceutical SUN.NS down 1.2%, Cipla CIPL.NS down 2%, Lupin LUPN.NS falls 3%, Glenmark Pharmaceuticals GLEN.NS dips 2.6%
** Shares of Dr. Reddy's Laboratories REDY.NS fall 1.4%, Zydus Lifesciences ZYDU.NS down 2.4% and Torrent Pharmaceuticals TORP.NS down 0.8%
(Reporting by Abhinav Parmar in Bengaluru)
Recent news on Zydus Lifesciences
See all newsIndia's Zydus Lifesciences posts lower profit as expenses outpace revenue growth
Brief: Zydus Lifesciences Q2 Consol Net Profit 9.26 Billion Rupees
Brief: Zydus Lifesciences Says Zylidac Bio And Prolific Machines Partner
Brief: Zydus Lifesciences Receives U.S. FDA Approval For Estradiol And Levonorgestrel Transdermal System
Brief: Zydus Lifesciences Says Zydus Sunshine Lifesciences Signs Agreement To Establish A Pharmaceutical Manufacturing Facility In Sri Lanka